GlassScriptPhysician profile
Paul M Dampf
NPI 1992996417
$12,394.72
in general payments reported to CMS, 2019-2025
40 companies · $834 in 2025
The $834 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,807 · 2020: $1,360 · 2021: $952 · 2022: $934 · 2023: $4,053 · 2024: $1,455 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,765 · Travel and Lodging: $2,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,765.37 |
| Travel and Lodging | $2,576.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,449.91 | 2019-2025 | Aveir, Gallant, Assurity |
| Medtronic Vascular, INC. | $1,258.81 | 2019-2020 | |
| Boston Scientific Corporation | $852.92 | 2019-2025 | Watchman Flx, Watchman Access System |
| Janssen Pharmaceuticals, INC | $650.52 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $564.48 | 2019-2025 | |
| Medtronic, INC. | $461.88 | 2021-2025 | Pulseselect, Na, Linq II |
| Pfizer INC. | $442.34 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $382.47 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.17 | 2019-2024 | Lifevest |
| Amgen INC. | $252.36 | 2019-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $221.68 | 2022-2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $161.49 | 2020-2025 | Nexletol |
| Irhythm Technologies, INC. | $146.98 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $127.53 | 2020-2024 | Onpattro |
| Abiomed | $126.86 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.75 | 2023-2025 | Jardiance |
| Amarin Pharma, INC. | $89.46 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $89.06 | 2019-2024 | |
| Baxter Healthcare | $85.04 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $76.25 | 2019-2023 | Farxiga |
| Biosense Webster, INC. | $70.52 | 2019-2025 | Carto 3 |
| Merck Sharp & Dohme LLC | $53.11 | 2025 | Verquvo |
| Lundbeck LLC | $43.54 | 2019-2020 | |
| Atricure, INC. | $33.40 | 2024 | |
| Cleerly, INC. | $26.90 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Astellas Pharma US INC | $24.95 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.92 | 2019 | |
| Akcea Therapeutics, INC. | $23.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $23.55 | 2019-2021 | |
| Biotronik INC. | $23.13 | 2024 | Acticor 7 Vr-T Dx |
| Cardiva Medical, INC. | $20.25 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Convatec INC. | $20.05 | 2022 | |
| Biogen, INC. | $18.45 | 2024 | Skyclarys |
| Kiniksa Pharmaceuticals International, Plc | $18.16 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $15.58 | 2023 | Inpefa |
| Cordis US Corp. | $15.39 | 2024 | Mynx Venous Vcd |
| Novo Nordisk INC | $14.27 | 2024 | Ozempic, Rybelsus |
| Acutus Medical, INC. | $12.64 | 2020 | |
| Genzyme Corporation | $11.66 | 2019 | |
| Gilead Sciences, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dampf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.